2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol

We are 2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol CAS:124936-74-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol
CAS.NO: 124936-74-9
Synonyms:
2-[3-BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPYL]-4-METHYLPHENOL HBR;
N,N-diiso-propyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine
2-[3-[BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPY]-4-METHYLPHENYLMONOHYDROBROMIDE(TOLTERODINE)
2-[3-[BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPYL]-4-METHYLPHENOL MONOHYDROBROMIDE
2-(3-(Bis(1-methylethyl)amino)-1-phenylpropyl)-4-methylphenylmonohydrobromide

Molecular Formula:C22H31NO
Molecular Weight: 325.48800

Physical and Chemical Properties:
Density: 1.0±0.1 g/cm3
Boiling point: 473ºC at 760 mmHg
Melting point: /
Flash point: 239.9ºC
Refractive index: 1.565

Specification:
Appearance: White powder
Purity:≥98%
Moisture Content: Not more than 1.0%
Impurity: Not more than 2.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Tolterodine CAS:124937-51-5
Intermediates of Tolterodine tartrate CAS:124937-52-6

Related News: The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.4-hydroxybenzaldehyde CAS:123-08-0 Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure.3,5-Dibromo-2-methoxypyridine The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide CAS:97-35-8 Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.